The speed-to-market imperative for life sciences capital delivery
Mckinsey and Company
AUGUST 4, 2025
Skip to main content The speed-to-market imperative for life sciences capital delivery August 4, 2025 | Article Life sciences companies are spending big on new capital projects. Life sciences companies for which time to market is a critical capability can embrace a time-based capital strategy.
Let's personalize your content